Secretary Robert F. Kennedy Jr. | Health and Human Services Seretary Robert F. Kennedy Jr. has selected seven new experts ...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take ...

The FDA issued a warning letter to Amneal Pharmaceuticals criticizing the drugmaker for failing to correct problems that led ...

During a tense and at times incendiary senate hearing Thursday, Robert F. Kennedy Jr. | During a tense and at times incendiary Senate hearing Thursday, Robert F. Kennedy Jr. blamed the pharmaceutical ...

In addition to encouraging people with HIV to pursue consistent treatment and mental and physical well-being, the “Choose U” campaign name also refers to the “U=U” movement, denoting how maintaining ...

ImmunoPrecise Antibodies has cemented a recent shift in its focus by adopting a new name: MindWalk. | ImmunoPrecise Antibodies has cemented a recent shift in its focus by adopting a new name: MindWalk ...

AstraZeneca is advancing plans to exit production in India by giving up its manufacturing license in the country some two ...

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing ...

A new campaign from Aflac aims to be more than just a one-off awareness push. | The “Check for Cancer” campaign, which ...

Amid ongoing upheaval at the FDA and other federal health agencies, prominent vaccine expert and Robert F. Kennedy Jr. critic ...

After joining multiple other drugmakers on the U.S. investment bandwagon earlier this year, Gilead Sciences is providing ...

United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a ...